Streetbeat News

Stock Prices

AXP

American Express shares are trading lower due to a Q3 revenue miss.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:05 pm

COHR

Coherent shares declined following a downgrade by B. Riley Securities from Buy to Neutral.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:04 pm

ERIE

Spruce Point Management has issued a report stating a short position on Erie Indemnity Company's shares, suggesting potential negative sentiment towards the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:03 pm

USM

VZ

United States Cellular shares rose following the announcement of selling part of its spectrum licenses to Verizon for $1 billion.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:03 pm

ACU

Acme United (AMEX:ACU) reported Q3 earnings per share of $0.54, missing the analyst estimate of $0.72 by 25%. Sales were $48.17M, below the expected $53.41M, marking a 4.4% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

October 18, 2024 | 1:02 pm

AVGO

MRVL

JPMorgan analyst Harlan Sur predicts a semiconductor up-cycle, with Broadcom and Marvell leading due to their strong positions in cloud and AI markets. The sector is expected to see positive growth into 2025, driven by demand for cloud infrastructure and custom chips. Clearing excess inventory and ongoing M&A activity are also positive factors.

Portfolio Pulse from Surbhi Jain

October 18, 2024 | 1:02 pm

HES

Analysts have varied opinions on Hess (NYSE:HES), with recent ratings showing a mix of bullish, indifferent, and bearish sentiments. The average 12-month price target has decreased by 4.94% to $165.0. Hess has shown strong financial performance with significant revenue growth and profitability, but its high debt-to-equity ratio raises concerns.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 1:01 pm

FTAI

FTAI Aviation (NASDAQ:FTAI) has received 15 analyst ratings in the last three months, with a majority being bullish. Analysts have raised their 12-month price targets, reflecting a positive outlook. Despite strong revenue growth, FTAI faces challenges with profitability and financial performance metrics.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 1:01 pm

CORT

Corcept Therapeutics (NASDAQ:CORT) has received a range of analyst ratings over the past three months, with a majority being bullish. Analysts have raised their 12-month price targets significantly, indicating positive sentiment. The company has shown strong revenue growth and net margins, but its return on equity is below industry standards.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 1:01 pm

SHW

Sherwin-Williams (NYSE:SHW) has been analyzed by 16 analysts, showing a range of perspectives from bullish to bearish. Recent analyst actions include several upgrades in price targets, with an average target of $394.31, marking an 8.44% increase from the previous average. Sherwin-Williams is the largest provider of architectural paint in the US, with strong financial metrics but a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 18, 2024 | 1:00 pm